Karyopharm Therapeutics Secures $48,200,000 Series B Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=69fcbbd5-bf9b-41da-bfea-67467530b0e3&Preview=1
Date
5/20/2013
Company Name
Karyopharm Therapeutics
Mailing Address
2 Mercer Road Natick, MA 01760
Company Description
Karyopharm Therapeutics is a biopharmaceutical company focusing on the development of novel drugs for the treatment of cancer, inflammation and diseases related to cell proliferation.
Website
http://www.karyopharm.com
Transaction Type
Venture Equity
Transaction Amount
$48,200,000
Transaction Round
Series B
Proceeds Purposes
The funds will be used to advance the Company’s pipeline of novel Selective Inhibitors of Nuclear Export (SINE) drug candidates for the treatment of advanced hematologic and solid tumors.
M&A Terms
Venture Investor
Undisclosed
Venture Investor
Delphi Ventures
Venture Investor
Undisclosed